First Republic Investment Management, Inc. Vyant Bio, Inc. Call Options Transaction History
First Republic Investment Management, Inc.
- $34.7 Billion
- Q3 2023
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding VYNT
# of Institutions
2Shares Held
213KCall Options Held
0Put Options Held
0About Vyant Bio, Inc.
- Ticker VYNT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,343,200
- Description
- Vyant Bio, Inc., a biotechnology company, discovers drugs for complex neurodevelopmental and neurodegenerative disorders. The company's central nervous system (CNS) drug discovery platform combines human-derived organoid models of brain disease, scaled biology, and machine learning. It focuses on identifying repurposed and novel small molecule c...